Filters
Vendor
Collection
Tags
- Breast Cancer Medicine (1)
- breast cancer relapse therapy (1)
- cancer treatment infusions (1)
- Chemotherapy (1)
- Chemotherapy Drug (1)
- doctor-only (1)
- Eribulin (1)
- Halaven (1)
- injectable anti-cancer agent (1)
- liposarcoma IV therapy (1)
- metastatic breast cancer (1)
- neutropenia prevention (1)
- oncology (1)
- sarcoma injection therapy (1)
Filters
Vendor
Collection
Tags
- Breast Cancer Medicine (1)
- breast cancer relapse therapy (1)
- cancer treatment infusions (1)
- Chemotherapy (1)
- Chemotherapy Drug (1)
- doctor-only (1)
- Eribulin (1)
- Halaven (1)
- injectable anti-cancer agent (1)
- liposarcoma IV therapy (1)
- metastatic breast cancer (1)
- neutropenia prevention (1)
- oncology (1)
- sarcoma injection therapy (1)
Breast Cancer Medicines for breast cancer relapse therapy
-
Sale 33%
Eribulin Mesylate Injection 1 mg/2 mL (0.5 mg/mL) Single-Dose Vial 2 mL (RX)
Original price $ 1,150.00Current price $ 775.00🔒 Medical License Required
Breast cancer medicines are designed to treat and manage various forms and stages of breast cancer by targeting cancerous cells and inhibiting their growth. These medicines can work through multiple mechanisms, such as hormone therapy to block hormones that fuel cancer growth, chemotherapy to kill rapidly dividing cells, targeted therapy to block specific proteins or genes involved in cancer progression, and immunotherapy to boost the body's natural defenses against cancer. They aim to reduce tumor size, prevent cancer spread, and improve survival rates.










